Lonza Raises 2016 Outlook as Profit Jumps on Savings, Demand

Updated on
  • Company sees profit increasing by double-digit amount
  • First-half profit jumps 20%, beating analyst estimates

Lonza Group AG raised its guidance for 2016 after demand for the Swiss company’s drug ingredient manufacturing services grew and savings bolstered margins in the first half.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.